Compounded Tirzepatide is a weekly GLP-1 injection influencing hunger and digestion. This dual-action GLP-1/GIP peptide activates key hormone receptors to regulate appetite and metabolic efficiency. Administered as a self-injection, it supports personalized dosing. As a compounded prescription medication, it is prepared by licensed pharmacies under supervision.
